Fig. 2From: Targeting Rad50 sensitizes human nasopharyngeal carcinoma cells to radiotherapyAd-RAD50 infection and the expression of mutant Rad50 in NPC cells. a The successful infection of Ad-EGFP and Ad-RAD50 in CNE1 cells. b The expression of mutant Rad50 protein in the Ad-RAD50 infected CNE1 cellBack to article page